𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma

✍ Scribed by JW Marsh; A Casavilla; S Iwatsuki; I Dvorchik; M Subotin; V Balan; J Rakela; V Subbotin; EP Popechitelev

Book ID
118686632
Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
144 KB
Volume
26
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Predicting the risk of tumor recurrence
Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma
✍ J W Marsh; A Casavilla; S Iwatsuki; I Dvorchik; M Subotin; V Balan; J Rakela; V πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 1 views

be either higher or lower than 1, i.e., having serological mark-to the exposure of interest, constitute a valid and well-accepted comparison group, which has been used in countless ers of infection by hepatitis B and C viruses could be either ''protective'' or ''predisposing'' factors for aplastic a

Total tumor volume predicts risk of recu
Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma
✍ Christian Toso; James Trotter; Alice Wei; David L. Bigam; Shimul Shah; Joshua La πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 241 KB

Criteria for the selection of candidates for liver transplantation in the presence of hepatocellular carcinoma (HCC) should accurately predict posttransplant recurrence while not excluding excessive numbers of patients from candidacy. Existing criteria are challenged by the limited accuracy of radio

Tumor recurrence following liver transpl
Tumor recurrence following liver transplantation for hepatocellular carcinoma: Role of tumor proliferation status
✍ Aileen E. Marshall; Simon M. Rushbrook; Sarah L. Vowler; Christopher R. Palmer; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 297 KB

The selection of patients with hepatocellular carcinoma for liver transplantation is currently based on the size and number of tumors to minimize the risk of recurrence. These criteria measure tumor bulk but may not reflect tumor behavior accurately. A biological marker of tumor behavior could aid w